oxymatrine has been researched along with Cancer of Colon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, T; Gao, Q; Liu, Y; Qian, L; Shen, G; Wang, Z; Wu, G | 1 |
| Hu, Z; Li, Y; Wang, S; Xiao, Z; Zhang, J; Zhang, Y | 1 |
| Ran, ZH; Xiao, SD; Xu, Q; Zou, J | 1 |
3 other study(ies) available for oxymatrine and Cancer of Colon
| Article | Year |
|---|---|
Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Colonic Neoplasms; Drug Synergism; Drugs, Chinese Herbal; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Organoplatinum Compounds; Oxaliplatin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinolizines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2016 |
Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice.
Topics: Adenocarcinoma; Alkaloids; Animals; Cachexia; Cell Line; Colonic Neoplasms; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Matrines; Mice; Mice, Inbred BALB C; Quinolizines; Tumor Necrosis Factor-alpha | 2008 |
Experimental study of the killing effects of oxymatrine on human colon cancer cell line SW1116.
Topics: Alkaloids; Antiviral Agents; Cell Death; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Quinolizines; Reverse Transcriptase Polymerase Chain Reaction; Telomerase; Tumor Cells, Cultured | 2005 |